OKYO Pharma Ltd
Clinical-stage biopharma developing drugs for eye diseases and chronic pain.
OKYO | US
Overview
Corporate Details
- ISIN(s):
- US6793451088
- LEI:
- Country:
- United States of America
- Address:
- 55 PARK LANE, LONDON
- Website:
- https://okyopharma.com/
- Sector:
- Manufacturing
Description
OKYO Pharma Ltd. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics for inflammatory eye diseases and chronic pain. The company's primary focus is on addressing significant unmet medical needs in neuropathic corneal pain (NCP) and dry eye disease (DED). Its lead product candidate, Urcosimod (OK-101), is a novel G protein-coupled receptor (GPCR) agonist that targets the chemerin receptor to produce anti-inflammatory and pain-reducing effects. OKYO is the first company to receive Investigational New Drug (IND) clearance from the FDA to clinically evaluate a drug specifically for NCP, a condition with no approved treatments. Urcosimod has also been granted Fast Track Designation by the FDA for the treatment of NCP.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-08-03 08:00 |
Company Presentation
|
English | 6.7 KB | ||
| 2020-07-31 17:30 |
Non Regulatory Upcoming Presentation
|
English | 6.7 KB | ||
| 2019-05-30 16:52 |
Holding(s) in Company
|
English | 55.8 KB | ||
| 2019-05-20 12:58 |
Result of General Meeting
|
English | 22.4 KB | ||
| 2019-05-01 02:00 |
OKYO Circular
|
English | 1.1 MB | ||
| 2019-04-26 09:00 |
Subscription and Waiver
|
English | 81.7 KB | ||
| 2019-03-07 08:00 |
Presentation of Preclinical Data
|
English | 18.4 KB | ||
| 2019-01-23 08:00 |
Corporate Update
|
English | 10.9 KB | ||
| 2018-11-30 17:06 |
Half-year Report
|
English | 223.5 KB | ||
| 2018-11-01 08:00 |
Expected Admission Date for Consideration Shares
|
English | 11.8 KB | ||
| 2018-10-24 09:00 |
Allotment of Ordinary Shares & Listing Application
|
English | 14.8 KB | ||
| 2018-09-30 02:00 |
Issuer Document
|
English | 49.3 KB | ||
| 2018-09-21 09:00 |
Appointment of Senior R&D Director
|
English | 18.9 KB | ||
| 2018-09-06 14:38 |
Result of AGM
|
English | 11.8 KB | ||
| 2018-08-22 14:13 |
Holding(s) in Company
|
English | 54.8 KB |
Automate Your Workflow. Get a real-time feed of all OKYO Pharma Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OKYO Pharma Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OKYO Pharma Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
